ArticleNeurochemical research2026
Expression and Localization of Branched-Chain Ketoacid Dehydrogenase E1 Subunits and LAT1 Transporter in Rat Retinal and Ocular Tissues.
Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Branched-chain amino acids (BCAAs) are essential for various metabolic and physiological functions. The enzymes responsible for breaking down and transporting them are organized in a tissue-specific manner, playing a crucial role in moving metabolites between cells but often being overlooked. This is particularly true for the rate-limiting enzyme, branched-chain keto-acid dehydrogenase (BCKD). To address this gap, our study investigated the expression and distribution of the BCKDE1 subunits and the BCAA transporter LAT1 in normal rat eye tissues, with a focus on the retina, by applying immunohistochemistry (IHC) and immunofluorescence (IF) with specific antibodies. Our findings show that BCKDE1 subunits are highly expressed in retinal neurons, specifically in the ganglion cell layer (GCL), inner and outer nuclear layers (INL/ONL), and the plexiform layers (IPL/OPL), although they are notably absent in Müller cells. Expression was also strong in the epithelial cells of the lens, iris, and ciliary body. Similarly, we observed LAT1 localized in the GCL and INL of the retina, as well as in the iris, ciliary body, and lens epithelium. These results complement our previous work, which indicated that branched-chain aminotransferase (BCAT) isozymes are widely expressed across most ocular tissues. Overall, this evidence strongly indicates that a complete BCAA metabolic pathway exists in the eye. This provides a comprehensive understanding of BCAA metabolism in eye tissues, highlighting its crucial role in maintaining amino acid balance, neurotransmitter production, and energy generation. Furthermore, this study lays a foundation for future studies on how disruptions in these enzymatic pathways might affect neurodegeneration in diabetic retinopathy and contribute to other eye conditions.
Indexed as
Identifiers
41998309What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.